Profile
Branden S.
Moriarity holds the position of Chief Scientific Officer at B-MoGen Biotechnologies, Inc., founded in 2015.
Dr. Moriarity holds the position of Chief Innovation Officer at Luminary Therapeutics, Inc., founded in 2019.
Dr. Moriarity is the founder of B-MoGen Biotechnologies, Inc. Dr. Moriarity is the founder of Luminary Therapeutics, Inc. Dr. Moriarity is also the founder of Catamaran Bio, Inc...
Branden S. Moriarity active positions
| Companies | Position | Start |
|---|---|---|
B-MoGen Biotechnologies, Inc.
B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology Provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing | Founder | 31/12/2014 |
Luminary Therapeutics, Inc.
Luminary Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops non-viral autologous cell therapies | Founder | 31/12/2018 |
Former positions of Branden S. Moriarity
| Companies | Position | End |
|---|---|---|
Catamaran Bio, Inc.
Catamaran Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company developing allogeneic, off the shelf CAR-NK cell therapies for cancer treatment | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
B-MoGen Biotechnologies, Inc.
B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology Provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing | Health Technology |
Luminary Therapeutics, Inc.
Luminary Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops non-viral autologous cell therapies | Commercial Services |
Catamaran Bio, Inc.
Catamaran Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company developing allogeneic, off the shelf CAR-NK cell therapies for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Branden S. Moriarity
















